Okayama University Scientific Achievement Repositorymetadata only
Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2–Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial
academic, research
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 631375
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.